Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0002108080-26-000004

Chief Commercial Officer sold 1,582 shares at $41.98 ($66,419)

From the SEC's structured data for this filing

Trades in this filing

Skelton Laurence Matthew · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-23 Sale : show line 1 in the form −1,582 $41.98 $66,419 64,218 D
Open-market sales · 1,582 sh · avg $41.98 · $66,419
Loading xslF345X05/form4-02262026_120224.xml…